Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc..
Filing timeline
BuySaleNur Nicholson
Insider track record
Disclosed buys
0
Disclosed sells
14
Signal history
Nur Nicholson: trading record in brief
Nur Nicholson (senior executive) discloses dealings in Apellis Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 28 January 2021 to 14 May 2026, the count stands at 29 filings.
On the market, this insider has only sold: 14 sales, €2.3M in total. Other entries cover 12 share grants and 1 option exercise. 2026 to date brings no purchases and 3 sales.
Most recently, on 14 May 2026, the filings show a transaction in Apellis Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nur Nicholson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
116,338 sharesCommon StockSEC:0001193125-26-224604:0
45,220 shares0Common StockSEC:0001492422-26-000074:0
7,725 shares@ US$21.76549.5% of flowCommon StockSEC:0001492422-26-000056:0
2,203 shares@ US$19.79292.5% of flowCommon StockSEC:0001492422-26-000040:0
2,618 shares@ US$22.18723.3% of flowCommon StockSEC:0001492422-26-000027:0
825 shares@ US$29.52361.5% of flowCommon StockSEC:0001127602-25-002383:0
3,948 shares@ US$30.42557.6% of flowCommon StockSEC:0001127602-25-001841:0
2,145 shares@ US$29.95824.1% of flowCommon StockSEC:0001127602-25-001625:0
36,426 shares0Common StockSEC:0001127602-25-001625:1
2,632 shares@ US$28.70214.9% of flowCommon StockSEC:0001127602-25-001201:0
3,452 shares@ US$58.136.8% of flowCommon StockSEC:0001127602-24-010127:1
7,768 shares@ US$57.30726.9% of flowCommon StockSEC:0001127602-24-010127:0
835 shares@ US$64.13823.3% of flowCommon StockSEC:0001127602-24-002746:0
2,593 shares@ US$64.99610.2% of flowCommon StockSEC:0001127602-24-001953:0
19,508 shares0Common StockSEC:0001127602-24-001437:0
1,857 shares@ US$66.80864.2% of flowCommon StockSEC:0001127602-24-001437:1
9,719 shares@ US$42.2114.1% of flowCommon StockSEC:0001127602-23-024445:1
10,631 shares@ US$46.1516.9% of flowCommon StockSEC:0001127602-23-024445:2
9,719 shares@ US$29.7617.9% of flowCommon StockSEC:0001127602-23-024445:0
825 shares@ US$58.501.7% of flowCommon StockSEC:0000899243-23-005786:1
9,886 shares0Common StockSEC:0000899243-23-005786:0
551 shares@ US$52.771.8% of flowCommon StockSEC:0001127602-23-002687:0
2,034 shares@ US$52.056.5% of flowCommon StockSEC:0001127602-23-002133:0
1,875 shares0Common StockSEC:0001127602-23-001499:0
22,580 shares0Common StockSEC:0001127602-23-001499:1
25 of 29 declarations
